Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

In vivo genome editing restores hemostasis in mouse model of blood clotting disorder

Using an innovative gene therapy technique called genome editing that hones in on the precise location of mutated DNA, scientists have treated the blood clotting disorder hemophilia in mice.

27 Jun 2011

Guidelines for pediatric use of polysomnography for sleep-disordered breathing before tonsillectomy

A multidisciplinary clinical practice guideline, "Polysomnography for Sleep-Disordered Breathing Prior to Tonsillectomy in Children" will be published as a supplement to the July issue of Otolaryngology-Head and Neck Surgery.

15 Jun 2011

UAB acquires first cell-processing workstation from SANYO

The University of Alabama at Birmingham has taken a significant step toward making sophisticated cell therapy a part of patient care with its acquisition of the first cell-processing workstation (CPWS) from SANYO North America Corporation (SANYO) in the United States.

9 Jun 2011

UAB first in U.S. with cell-processing workstation

8 Jun 2011

Patients with sickle cell disease may require higher, frequent doses of morphine

Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.

13 May 2011

Hydroxyurea safe and effective for infants, toddlers with sickle-cell disease

In what is being hailed as a significant advance in the treatment of children with sickle cell anemia, a drug commonly used to treat adults has been shown to be safe and effective in children.

13 May 2011

New study finds nitric oxide gas appears to affect source of sickle cell pain crises

Nitric oxide gas appears to directly impact the source of the classic, disabling pain crises of sickle cell disease, Georgia Health Sciences University researchers report.

10 May 2011

Selexys begins patient enrollment in SelG1 Phase I study for sickle cell disease

Selexys Pharmaceuticals announced today that it has initiated enrollment in a Phase I clinical study of its lead compound, SelG1, a humanized anti-P-selectin antibody.

5 May 2011

Frequently hospitalized patients may need a specialist focused on their care: Hospital care expert

Declining rates of hospitalization have discouraged primary care doctors from seeing their patients in the hospital and encouraged the growing use of "hospitalists," a new physician specialty focused on the care of hospitalized patients.

30 Apr 2011

HemaQuest initiates HQK-1001 Phase 2 study in sickle cell disease

HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that clinical investigators have enrolled the first patient in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.

26 Apr 2011

Malaria diagnosis made easy with smart phone app

Malaria kills nearly 1 million children a year, mostly in developing countries with little infrastructure and few resources. For the 9th Imagine Cup 2011 - a student contest sponsored by Microsoft, student entrants were asked to “imagine a world where technology helps solve the toughest problems.” Tristan Gibeau 25, a graduate computer engineering student at the University of Central Florida in Orlando and his team developed an ‘app’, LifeLens, to detect malaria.

10 Apr 2011

Pregnancy and pre-pregnancy genetic tests approved for all

According to a government’s advisory body on genetics, genetic tests for conditions that can be passed on to future generations should be more widely available before pregnancy. There are “no specific social, ethical or legal principles” against preconception screening, a Human Genetics Commission report has ruled. It said testing should be available to any couples who may benefit from it. The UK National Screening Committee will now consider the findings.

7 Apr 2011

Texas Children's Hospital and Baylor College of Medicine create Texas Children's Center for Global Health

Texas Children's Hospital and Baylor College of Medicine (BCM) today announced the creation of the Texas Children's Center for Global Health and the appointment of renowned physician-scientist Dr. Russell E. Ware as director.

31 Mar 2011

State laws regarding baby blood samples analyzed

State laws and policies governing the storage and use of surplus blood samples taken from newborns as part of the routine health screening process range from explicit to non-existent, leaving many parents ill-informed about how their babies' left over blood might be used, according to a team led by a member of the Johns Hopkins Berman Institute of Bioethics, in collaboration with researchers from the University of Utah. A report on their analysis of the subject is published March 28 in the journal Pediatrics.

28 Mar 2011

Cortex reports net loss of $0.01 per share for quarter ended December 31, 2010

Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of $984,000, or $0.01 per share for the quarter ended December 31, 2010 compared with a net loss of $1,599,000, or $0.02 per share for the corresponding prior year period.

18 Mar 2011

Researchers develop novel system to show how specific mutations can induce glioblastoma

Mutations in three pathways important for suppressing tumors cooperate to launch glioblastoma, an aggressive brain tumor that strikes children and adults. But new research from St. Jude Children's Research Hospital scientists shows those changes alone are not sufficient to cause cancer.

15 Mar 2011

Research: CREBBP mutation may help cancer resist steroid treatment, fuel ALL's return

Despite dramatically improved survival rates for childhood acute lymphoblastic leukemia, relapse remains a leading cause of death from the disease. Work led by St. Jude Children's Research Hospital investigators identified mutations in a gene named CREBBP that may help the cancer resist steroid treatment and fuel ALL's return.

10 Mar 2011

NYBC urges African American, Hispanic descent to donate blood for special patients

A hospitalized single mother from Queens is calling for more African Americans to become blood donors, so that she and many others may be able to live. People may call New York Blood Center at 1-800-933-BLOOD or visit www.nybloodcenter.org for more information about giving blood, and where to donate.

22 Feb 2011

SynthRx to become wholly-owned subsidiary of ADVENTRX

ADVENTRX Pharmaceuticals, Inc. today announced that it has entered into a definitive agreement to acquire SynthRx, Inc., a private biotechnology company developing a purified form of a rheologic and antithrombotic agent, poloxamer 188.

14 Feb 2011

Silent strokes can cause long-term cognitive, learning deficits in children with sickle cell disease

Silent strokes, which have no immediate symptoms but could cause long-term cognitive and learning deficits, occur in a significant number of severely anemic children, especially those with sickle cell disease, according to research presented at the American Stroke Association's International Stroke Conference 2011.

13 Feb 2011

Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

In vivo genome editing restores hemostasis in mouse model of blood clotting disorder

Guidelines for pediatric use of polysomnography for sleep-disordered breathing before tonsillectomy

UAB acquires first cell-processing workstation from SANYO

UAB first in U.S. with cell-processing workstation

Patients with sickle cell disease may require higher, frequent doses of morphine

Hydroxyurea safe and effective for infants, toddlers with sickle-cell disease

New study finds nitric oxide gas appears to affect source of sickle cell pain crises

Selexys begins patient enrollment in SelG1 Phase I study for sickle cell disease

Frequently hospitalized patients may need a specialist focused on their care: Hospital care expert

HemaQuest initiates HQK-1001 Phase 2 study in sickle cell disease

Malaria diagnosis made easy with smart phone app

Pregnancy and pre-pregnancy genetic tests approved for all

Texas Children's Hospital and Baylor College of Medicine create Texas Children's Center for Global Health

State laws regarding baby blood samples analyzed

Cortex reports net loss of $0.01 per share for quarter ended December 31, 2010

Researchers develop novel system to show how specific mutations can induce glioblastoma

Research: CREBBP mutation may help cancer resist steroid treatment, fuel ALL's return

NYBC urges African American, Hispanic descent to donate blood for special patients

SynthRx to become wholly-owned subsidiary of ADVENTRX

Silent strokes can cause long-term cognitive, learning deficits in children with sickle cell disease

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in